Increasing evidence suggests that the mesolimbic reward system plays critical roles in the regulation of depression and nociception; however, its circuitry and cellular mechanisms remain unclear. In this study, we investigated the output-specific regulatory roles of dopaminergic (DA) neurons within the ventral tegmental area (VTA) in depressive-like and nociceptive behaviors in mice subjected to unpredictable chronic mild stress (CMS), using the projection-specific electrophysiological recording, pharmacological manipulation, behavioral test, and molecular biology technologies. We demonstrated that CMS decreased the firing activity in VTA projecting to medial prefrontal cortex (VTA → mPFC), but not in VTA to nucleus accumbens (VTA → NAc), DA neurons. However, both VTA → mPFC and VTA → NAc DA neurons showed increased firing activity in response to morphine perfusion in CMS mice. Behavioral results showed that intra-VTA microinjection of morphine (25.5 ng/0.15 mL) relieved depressive-like behaviors, intriguingly, accompanied by a thermal hyperalgesia. Furthermore, the relief of depressive-like behaviors induced by intra-VTA injection of morphine in CMS mice could be prevented by blocking brain-derived neurotrophic factor (BDNF) signaling and mimicked by the administration of exogenous BDNF in mPFC rather than in NAc shell. Nociceptive responses induced by the activation of VTA DA neurons with morphine in CMS mice could be prevented by blocking BDNF signaling or mimicked by administration of exogenous BDNF in NAc shell, but not in mPFC. These results reveal projection-specific regulatory mechanisms of depression and nociception in the mesolimbic reward circuitry and provide new insights into the neural circuits involved in the processing of depressive and nociceptive information.
Introduction
Chronic pain is undoubtedly a distressing condition and might be associated with neuropsychiatric diseases. 15, 48 There is increasing interest in the involvement of the mesocorticolimbic system, which is composed of dopaminergic (DA) neurons of the ventral tegmental area (VTA) and their projections to target areas, in various neuropsychiatric and neurological disorders including depression and chronic pain. 4, 20, 32, 42, 44, 47, 67 VTA DA neurons projecting to different target regions show great functional heterogeneity, which may play important roles in mediating different clinical manifestations in neurological diseases. 32, 50, 62, 67 It has been demonstrated that projections from the VTA to the nucleus accumbens (VTA → NAc) and from the VTA to the medial prefrontal cortex (VTA → mPFC) displayed heterogeneous intrinsic properties and played vital roles in stress-induced depression, 12, 14, 31, 58 nociceptive modulation, 38, 41, 64 and painrelated affective behaviors. 43, 51 For example, a tract-tracing experiment in mice showed less than 1% overlap of VTA DA neurons that project to the mPFC and NAc. 12 In the repeated social defeat-induced depression model, VTA → NAc DA neurons had significantly higher firing rates, yet the firing rates of VTA → mPFC DA neurons were dramatically decreased. The activation of VTA → NAc or inhibition of the VTA → mPFC pathways induced susceptibility to social defeat stress. 12 In contrast to these findings, in the chronic mild stress (CMS)-induced depression model, photoactivation of VTA DA neurons rescued depressive-like phenotypes and selective inhibition of VTA DA neurons induced depressive-like behaviors. 58 Studies have also implicated the VTA → NAc pathway in nociceptive modulation. 38, 67 It is demonstrated that a subpopulation of VTA DA neurons exhibits excitatory responses to noxious Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
stimuli. 9, 21, 34 Furthermore, the VTA → NAc pathway has been shown to be important in pain relief, 43 motivated behavior, 51 and the analgesic effects of placebo and stress. 2, 52, 57 Despite few experiments exploring the role of the VTA → mPFC pathway in the regulation of nociception, some studies have revealed the importance of the mPFC in nociceptive processes and painrelated emotional experiences. 6, 29, 41, 63 These findings, on the one hand, support the regulatory roles of the heterogeneous mesocorticolimbic circuit in depression and nociception, and on the other hand, suggest that the effects of stress and nociception on the mesocorticolimbic system are highly complex. Therefore, a better understanding of the circuit and molecular mechanisms of depression and nociception in this emotion-related system is needed.
Previous studies have indicated that brain-derived neurotrophic factor (BDNF) might be involved in the pathogenesis of depression and nociception. 7, 39, 54, 67 Brain-derived neurotrophic factor within the mPFC plays pivotal roles in the modulation of depression, and BDNF normalization in mPFC accounts for the effects of antidepressants. 39 Recent studies have also explored the important modulatory roles of BDNF signaling in the mesocorticolimbic circuit in nociception and nociceptionrelated emotions processing. 45, 56, 67 These studies led to the suggestion that BDNF in the mesocorticolimbic circuit might contribute to the regulation of depression and nociception.
In this study, using a CMS-induced mouse depression model, we reveal a projection-specific modulation of depression and nociception in the mesolimbic reward circuitry and provide new insights into the neural circuits and molecular mechanisms involved in the processing of depressive and nociceptive information.
Materials and methods

Animals
Male Kunming mice (aged 7 weeks, Experimental Animal Center of Xuzhou Medical University, China) were housed (n 5 5 per cage) in a temperature-controlled vivarium, with ad libitum access to food and water on a 12-hour light/dark cycle. All experiments were performed during the light cycle. For ethological tests, each mouse was randomly allotted for a given test alone, and all the behavioral tests were conducted by double-blind randomization in a silent room. All experimental protocols conformed to the National Institutes of Health's Guide for Care and Use of Laboratory Animals as well as the Committee for Research and Ethical Issues of the International Association for the Study of Pain.
Chronic unpredictable mild stress procedures
The procedures were conducted to establish an animal model of depression. After 7 days of acclimation to cages, mice were subjected to 5 consecutive weeks of CMS, with slight modifications of the methods and periods of stressors. 55 The CMS procedures consisted of water deprivation (24 hours), fasting (24 hours), day/night inversion, damp bedding (200 mL water in padding), cage tilted 45˚overnight, 4˚C cold bath (5 minutes), and tail pinching (3 minutes, 1.5 cm from the tail tip), with 5 to 7 stressors involved at random each week.
Stereotaxic surgery
To prevent the impacts of stress on affective-like behaviors, the mice were anesthetized with continuous inhalation of ether (2%) throughout the intracerebral injection. The mice were mounted on a stereotaxic apparatus (Stoelting Co, Wooddale, IL), followed by sterilization, scalp incision, and cranium exposure. Reagents were dissolved in normal saline and unilaterally microinjected with 33-gauge needle into (in millimeter): VTA (anterior-posterior, 23.5; lateral-medial, 0.5; dorsal-ventral, 24.0), mPFC (anteriorposterior, 11.8; lateral-medial, 0.4; dorsal-ventral, 22.5), or NAc shell (anterior-posterior, 11.6; lateral-medial, 0.8; dorsal-ventral, 24.5) at a rate of 0.1 mL/minute followed by 5 minutes of rest to prevent backflow. Morphine hydrochloride (Mor, 25.5 ng/0.15 mL, H21022436, Shenyang No.1 Pharmaceutical Co Ltd, China) or baclofen (Bac, 0.16 pg/0.15 mL, B5399; Sigma-Aldrich Co, LLC, St. Louis, MO) was injected into the VTA. The retrograde green fluorescent tracer Lumafluor (0.3 mL, Lumafluor Inc, Durham, NC), BDNF (10 ng/0.2 mL, B3795; Sigma-Aldrich), or TrkB-Fc (20 ng/0.2 mL, T8694; Sigma-Aldrich) was administered in the mPFC or NAc shell. For verification of injection sites, 50-mm thick brain slices with the region of the VTA, mPFC, or NAc shell were cut, followed by staining with the neutral red solution (1: 2000) and inspected with light microscopy. Only successive penetrations located in the VTA, mPFC, or NAc shell were used for data analysis.
Tail suspension test
The tail suspension test (TST) was performed, 16 with the murine caudal tip adhered on a suture and suspended 50 cm above the floor padding. Immobility was defined as cessation of any bodily movements. The immobility duration for each subject within 5 minutes was recorded.
Open-field test
The open-field test (OFT) was performed as previously reported, except for minor modifications in the size of the arena. 49 All mice were placed in a black plastic open-field apparatus (100 3 100 3 40 cm), illuminated by a 30-W white fluorescent light 2 m overhead. The ANY-maze tracking system (version 4.84; Stoelting Co, IL) divided the field into 9 identical virtual squares, and the number of line crossings within 10 minutes was recorded.
Social interaction test
The social interaction test was performed as previously reported, with minor modifications of the position of the social target. 28 Each mouse was placed in a cubic box (40 3 40 3 40 cm). A virtual arena (12 3 10 cm), defined as "interaction zone" was set on the box floor adjacent to another box (103 10 3 20 cm) housing an unacquainted target mouse, with a wire mesh window in between. The total duration of each experimental mouse in the interaction zone within 3 minutes was calculated with TopScan Lite software (Clever Sys, Inc, Reston, VA).
Sucrose preference test
The sucrose preference test was performed for a 24-hour duration as from mouse placement (5:00 PM) in individual cages, with ad libitum access to 1% sucrose solution or tap water in 2 bottles (50 mL) fitted with ball-point sipper tubes. 28 To obviate location preference, the bottles were exchanged every 12 hours, with the liquids weighed at the end of the accommodation (5:00 PM the next day) and sucrose preference calculated as a percentage of sucrose solution intake relative to total consumption. In this study, 4 hours, 1 day, and 3 days time points of the sucrose preference indicated the calculated sucrose preference from 4 hours, 1 day, and 3 days after intracranial injection to 24 hours later.
Paw withdrawal latency test
The paw withdrawal latency (PWL) test was conducted as previously described. 22 Each mouse was displaced in a transparent plastic box (7 3 9 3 11 cm) located on a 3-mm thick plexiglass pane of IITC Plantar Analgesia Meter (IITC Life Science Inc, CA) for acclimation for 1 hour. The calcaneal pad of the hind paw was heated by a portable focused heater from underneath. The PWL was defined as the period from the commencement of focused heating to the onset of paw licking or lifting, with the thermal intensity adjusted to achieve basal PWL in 8 to 14 seconds and an automatic cutoff preset to 25 seconds to avoid localized insults. The tests were in triplicate for each mouse at an interval of 5 minutes, with the mean PWL calculated as the thermal nociceptive threshold.
Ex vivo cell-attached electrophysiology
Cell-attached recordings were obtained from VTA DA neurons in acute brain slices. 
Immunohistochemistry
The mice subjected to microinjection of retrograde green fluorescent tracer Lumafluor in either mPFC or NAc shell were anesthetized (10% chloral hydrate, 300 mg/kg, i.p.), followed by intracardial perfusion with 4% paraformaldehyde in phosphate-buffered saline (pH 7.4). The brains were postfixed overnight, transferred to 30% sucrose for 48 hours, and sectioned (30 mm) using a freezing microtome (Leica Microsystems, model VT1000S). The slices were blocked in 10% donkey serum and exposed overnight to mouse antityrosine hydroxylase (TH) (1:500, MAB318, Millipore, CA). The antibodies were labeled with donkey anti-mouse Alexa 594 (1:400, R37115, Invitrogen). Sections were imaged at 320 magnification for analyses. Cell counting was performed manually.
In vivo electrophysiology
Spontaneous firing from putative VTA DA neurons in mice was recorded. 11, 40 Under chloral hydrate (10%, 300 mg/kg, i.p.) anesthesia, a glass-coated tungsten microelectrode with an impedance of 0.6 to 1.0 MV (Frederick Haer) was advanced toward the VTA through a guiding tube by a micromanipulator. The coordinates of VTA were as follows (in millimeter): anteriorposterior, 23.30 to 23.70; lateral-medial, 0.40 to 0.60; and dorsal-ventral, -3.5 to 24.5. The multichannel workstation (Alpha Lab SnR, Alpha Omega) was used for the collection, amplification, and filtration of the action potentials of neurons. Identification of spontaneous firings of VTA DA neurons was based on the electrophysiological properties 11 : (1) prolonged duration (.1.2 ms); (2) triphasic action potentials with negative waveforms; (3) low firing frequencies (,10 Hz); and (4) spontaneous single and burst (an interval , 80 ms between spikes) firings. Steady in vivo firings were recorded before and subsequent to morphine injection (25.5 ng/0.15 mL) in the VTA for 5 minutes, respectively.
Western blotting analyses
Tissue blocks of mPFC and NAc shell were punched 4 hours and 1 hour after intra-VTA injection, respectively. The tissues were homogenized in lysis buffer containing protease and phosphatase inhibitors, followed by centrifugation (13,000 rpm, 15 minutes, 4˚C). With the supernatants collected and protein concentrations measured, the supernatants were adjusted to the identical protein concentration across groups. The samples (40 mg protein per lane) were electrophoresed by 10% SDS-PAGE and transferred onto PVDF membranes (Millipore). The membranes were rinsed thrice and blocked in 5% wt/vol skimmed milk for 2 hours at 25˚C, followed by incubation in primary polyclonal rabbit anti-BDNF (1:1000, sc-546, Santa Cruz) or polyclonal rabbit anti-b-Tubulin (1:1000, E021040-01, Earthox) antibody overnight at 4˚C. Afterward, the bands were rinsed and incubated in alkaline phosphataselabeled secondary antibody (1:1000, AP-1000, VECTOR) (2 hours, 25˚C) and were visualized by a BCIP/NBT kit (S3771, Promega). We detected a band between 11 kDa and 15 kDa (more than 12 kDa), which was comparable to a study concerning BDNF expression in mouse cortex and striatum, 65 indicating mature BDNF. b-Tubulin served as the standard of comparison, and the grayscale intensity of bands was analyzed by ImageJ software.
Brain-derived neurotrophic factor quantification by enzyme-linked immunosorbent assay
Quantification of BDNF release in mPFC and NAc shell was performed 4 hours and 1 hour after microinjection of morphine into the VTA, respectively. Following the procedures of preparing brain slices for ex vivo cell-attached electrophysiology, coronal slices of 300 mm were obtained while submerged in a slush of sucrose aCSF. The mPFC and NAc shell slices were trimmed from the whole coronal slices and were then transferred and maintained in aCSF saturated with carbogen at 37˚C for 45 minutes. Fifty microliters of the cultured supernatant of mPFC and NAc shell slices for every sample was collected for assay. Brain-derived neurotrophic factor protein levels in the cultured supernatant of mPFC and NAc shell slices were analyzed using the Mouse Brain Derived Neurotrophic Factor ELISA KIT (MBS724249, MyBioSource) according to the manufacturer's protocol. Briefly, 50 mL of standards or samples were added and incubated for 1 hour at 37˚C in 96-well microtiter plates coated with anti-BDNF monoclonal antibody. To quantitatively determine the amount of BDNF in the sample, a standardized preparation of horseradish peroxidase (HRP)-conjugated polyclonal antibody, specific for BDNF, was added to each well. The enzyme (HRP) and substrate are allowed to react over a short incubation period. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution, and the color change is measured spectrophotometrically at a wavelength of 450 nm.
Data analysis and statistics
Statistical analyses were conducted with GraphPad Prism 5.0. Values in graphs are expressed as mean 6 SEM. Student t test was used to compare the electrophysiological data. One-way ANOVA was conducted to analyze the Western blotting and ex vivo recording data, followed by the Tukey post hoc test. Twoway repeated measures ANOVA was performed to analyze the 2 factors (grouping and timing) of behavioral and electrophysiological data, followed by Bonferroni post hoc tests when appropriate. Sample sizes are indicated in the figure legends, and differences of P , 0.05 were considered statistically significant.
Results
3.1.
The changes of firing rates in the VTA → mPFC and VTA → NAc dopaminergic neurons in chronic mild stress mice Chronic mild stress mice showed significant depressive-like phenotypes, that is decreased line crossings during the OFT (Fig. 1A1) , prolonged immobility duration during the TST (Fig. 1A2) , decreased social interaction (Fig. 1A3) , and diminished sucrose preference (Fig. 1A4) . However, after CMS, no significant differences in thermal nociceptive threshold (paw withdraw latency, PWL) were found (Fig. 1B) . It is well accepted that VTA DA neuronal firing rates show great heterogeneity, 31, 37 which underlies its extensive effects on regulating different behavioral responses. Therefore, it was critical for us to elucidate the changes of firing rates in VTA DA neurons projecting to mPFC or NAc shell after CMS. To answer this question, the retrograde green fluorescent tracer was infused into mPFC or NAc shell to label the mPFC-or NAc shellprojecting VTA neurons (supplemental digital content 1, Figures 1 and 2 , available online at http://links.lww.com/ PAIN/A494), respectively, and the firing rates in the Lumafluor-labeled neurons were recorded (Fig. 1C) . Immunohistochemistrical analysis showed that most of the Lumafluorlabeled neurons were TH-positive neurons (Fig. 1D, E) . Projection-specific electrophysiological data showed that the firing rates of VTA → mPFC putative DA neurons were significantly inhibited in CMS mice when compared with stress-naive (Ctrl) mice (Fig. 1F ), yet no significant differences were observed in the VTA → NAc DA neurons between the groups (Fig. 1G) . These data indicated that CMS resulted in circuit-specific modulation of firing activity in the mesocorticolimbic circuits.
Elevated responses to morphine in the VTA dopaminergic neurons in chronic mild stress mice
Our ex vivo recording data are also supported by a previous report that in vivo firing rates of VTA DA neurons were significantly reduced in CMS mice. 60 Therefore, enhancement of VTA DA neuronal firing should relief CMS-induced depressive-like behaviors. A previous study has demonstrated that acute microinjection of morphine (60 ng/0.06 mL) can activate VTA DA neurons in stress-naive rats. 25 Thus, we wanted to first explore the effects of intra-VTA administration of morphine on the in vivo firing rates of putative VTA DA neurons in anesthetized CMS mice (supplemental digital content 1, Figure 3 , available online at http://links.lww.com/PAIN/A494). Here, intra-VTA microinjection of morphine chloride (25.5 ng/ 0.15 mL) was used as a tool to activate putative VTA DA neurons. We found that CMS stress causes a reduction in the firing rates of VTA DA neurons ( Fig. 2A, B) . Furthermore, intra-VTA infusion of morphine hydrochloride (25.5 ng/0.15 mL) markedly elevated the firing rates of VTA DA neurons in CMS mice, but not in stress-naive mice ( Fig. 2A, B) . To determine if there is a circuit-specific effect of morphineinduced activation of VTA DA neurons in CMS mice, we performed projection-specific ex vivo recordings with bath application of morphine (0.22 mg/mL). We first replicated our results that CMS mice showed decreased firing rates in the VTA → mPFC DA neurons when compared with Ctrl mice (Fig. 2C, D) , and there are no differences in firing rates of the VTA → NAc DA neurons between CMS and Ctrl mice (Fig. 2E, F) . We next revealed that morphine infusion significantly increased the firing rates of both the VTA → mPFC and VTA → NAc DA neurons in CMS mice, but not in stressnaive mice (Fig. 2C-F) . These data suggest that persistent stress induced latent sensitization of VTA DA neurons, which could be unmasked by exogenous morphine administration.
Activation of VTA dopaminergic neurons relieved depressive-like behaviors but produced thermal nociceptive responses in chronic mild stress mice
Next, we assessed the effects of the activation of VTA DA neurons on depressive-like behaviors and nociception in CMS mice undergoing intra-VTA injection of morphine (25.5 ng/0.15 mL). Present results found that VTA administration of morphine relieved depressive-like behaviors at 4 hours and 1 day after administration, as evidenced by increased line crossings in OFT (Fig. 3A1) , decreased immobility duration in TST (Fig. 3A2) , prolonged interaction in the social interaction test (Fig. 3A3) , and enhanced sucrose preference (Fig. 3A4) . Chronic mild stressinduced depressive-like behaviors appeared again at 3 days after the activation of VTA DA neurons by morphine (Fig. 3A1-4) . Surprisingly, intra-VTA injection of morphine produced a transient thermal nociceptive response, as indicated by the decreased PWL in CMS mice at 0.5 and 1 hour after intra-VTA infusion (Fig.  3B-D) . To further confirm this apparent paradoxical finding, we pharmacologically increased VTA DA neuronal firing rates through another mechanism by VTA microinjection of a low concentration of baclofen (0.16 pg/0.15 mL), which has been demonstrated to increase excitability of VTA DA neurons 13, 30 and then performed depressive-like behaviors and thermal nociceptive tests. A similar finding was also found after baclofen injection ( Fig. 3E-H) . These data suggest that pharmacological activation of VTA DA neurons in CMS mice relieves depressive-like behaviors, yet induces nociceptive responses.
3.4. Brain-derived neurotrophic factor in the VTA → mPFC pathway mediated the regulation of depressive-like behaviors in chronic mild stress mice Brain-derived neurotrophic factor in the mesolimbic reward system has been shown to be involved in the repeated social defeat-induced depressive-like behaviors. 7, 28, 62 Here, we explored whether BDNF signaling in this emotional circuitry is implicated in the regulation of depressive-like behaviors and nociceptive responses by the activation of VTA DA neurons underlying the CMS-induced state of depression.
Western blot analysis showed that BDNF expression in mPFC was downregulated in CMS mice and was reversed 4 hours after intra-VTA injection of morphine (Fig. 4A1) . Moreover, using ELISA assay, we found that the basal release of BDNF in cultured slices of the mPFC was significantly decreased in CMS mice as compared with control mice, which was increased 4 hours after intra-VTA injection of morphine (Fig. 4A2) . With these results demonstrating that morphine administration in the VTA leads to increased release of BDNF in the mPFC in CMS mice, we wanted to determine whether exogenous administration of BDNF (10 ng/0.2 mL) in the mPFC could change depressive-like phenotypes and nociception in CMS mice.
Our data showed that injection of exogenous BDNF in mPFC induced antidepressant-like effects in CMS mice including increased line crossings in the OFT (Fig. 4B1) , attenuated time spent immobile in the TST (Fig. 4B2) , reversed social avoidance during a social interaction test (Fig. 4B3) , and increased sucrose preference (Fig. 4B4) . However, BDNF administration into mPFC did not alter thermal nociceptive threshold in the CMS mice (Fig. 4C, D) . These data indicate that the modulation of BDNF signaling in mPFC might participate in the regulation of depressive-like behaviors, but not nociception, induced by CMS.
To further illustrate the relationship between the upregulation of BDNF expression in the mPFC and the relief of depressive-like behaviors by the activation of VTA DA neurons, we blocked BDNF signaling by the injection of TrkB-Fc (20 ng/0.2 mL) into the mPFC 10 minutes before morphine or saline infusion into the VTA. Assessment of depressive-like behaviors revealed that there were no significant differences in line crossings in OFT (Fig. 4E1) , immobility duration in TST (Fig. 4E2) , social interactions (Fig. 4E3) , and sucrose consumption (Fig. 4E4) between CMS mice receiving both injections of TrkB-Fc in mPFC and saline or morphine in the VTA. These data suggest that the inhibition of BDNF signaling in the mPFC could abolish the antidepressant-like effects observed with morphine activation of VTA DA neurons. However, blocking of BDNF signaling in mPFC failed to change the thermal nociceptive responses by VTA DA neuronal activation in CMS mice, as indicated by the shortened PWL (Fig. 4F-H) . Together, these findings revealed that BDNF signaling in the VTA → mPFC pathway regulates depressive-like behaviors, but not nociceptive responses, after the activation of VTA DA neurons in the CMS state. 3.5. Brain-derived neurotrophic factor in VTA → NAc pathway mediated the regulation of nociceptive behaviors in brain-derived neurotrophic factor mice Next, we investigated whether BDNF signaling in the VTA → NAc pathway is implicated in the regulation of depressive-like behaviors and nociceptive responses by the activation of VTA DA neurons underlying state of depression. Measurement of BDNF expression in the NAc shell showed no significant alterations after CMS. However, intra-VTA injection of morphine significantly upregulated BDNF levels in NAc shell in CMS mice, but not in the control mice (Fig. 5A) . Quantification of BDNF by ELISA found that intra-VTA injection of morphine also increased the release of BDNF in NAc shell in CMS mice, but not in control mice (Fig. 5A2) .
To further study the role of BDNF signaling in the VTA → NAc pathway in the regulation of depressive-like behaviors and nociceptive responses, we next tested the effects of exogenous administration of BDNF (10 ng/0.2 mL) in NAc shell on depressivelike behaviors and thermal nociceptive threshold in CMS mice. The results indicated that no significant alterations were found in depressive-like behavioral tests including the line crossings during OFT (Fig. 5B1) , immobility duration in TST (Fig. 5B2) , social interaction behaviors (Fig. 5B3) , and sucrose preference (Fig. 5B4) after BDNF injection in NAc shell. However, intra-NAc shell injection of BDNF decreased PWL in CMS mice, but not in control mice (Fig. 5C, D) .
To explore the relationship between the upregulation of BDNF expression in the NAc shell and VTA DA activation-induced thermal nociceptive responses in CMS mice, we blocked BDNF signaling by the injection of TrkB-Fc (20 ng/0.2 mL) into the NAc 10 minutes before morphine or saline infusion into the VTA in CMS mice. The results found that TrkB-Fc injection in NAc shell did not change the antidepressant-like effects by morphineinduced activation of VTA DA neurons (Fig. 5E1-4) . However, the thermal nociceptive responses induced by intra-VTA injection of morphine were prevented by intra-NAc shell injection of TrkB-Fc (Fig. 5F-H) . Collectively, these findings indicated that BDNF signaling in the VTA → NAc pathway might act as a potential modulator for nociception, but not for depressive-like behaviors, after the activation of VTA DA neurons in the CMS state.
Discussion
Our behavioral, electrophysiological, and neuropharmacological results consistently demonstrated that CMS decreased VTA DA neuronal firing activity in the VTA → mPFC pathway, but not in the VTA → NAc pathway, and the VTA DA neurons in CMS mice showed an enhanced response to morphine administration when compared with stress-naive mice. These data suggested that CMS induced the heterogeneous regulation of VTA DA neuronal activity in a circuitdependent manner. Our study is consistent with previous findings that VTA DA neuronal activity was inhibited by aversive stimuli and optical activation of VTA DA neurons rescued CMS-induced depression phenotype. 58, 59 In addition, a significant reduction in the burst activity of VTA DA neurons was detected in the Flinders sensitive line (FSL) rat, a genetic animal model of depression. 19 However, contradictory results were found in chronic restraint 3 and social defeat 7, 28 stress-induced depression models. These studies reflect the heterogeneous properties of VTA DA neurons and their responses to different forms of stressors. Further study of VTA DA neuronal activity in an anatomical-, input-or output-dependent manner might contribute to interpreting these paradoxical findings.
Next, we found that relief of depressive-like behaviors by intra-VTA injection of morphine in CMS mice was intriguingly accompanied by a significant thermal nociceptive response. The similar effects were also revealed after intra-VTA injection of a low dose of baclofen, which preferentially inhibited GABAergic neurons resulting in the disinhibition of VTA DA neurons and increase of its firing activity. 13, 30 Previous studies have shown that NAc shell, but not mPFC, projecting VTA DA neurons displayed large hyperpolarization-activated current (Ih). Compared with VTA → mPFC DA neurons, VTA → NAc DA neurons displayed lower membrane excitability and slower pacemaker activity. 26, 32 These intrinsic modulatory heterogeneities in VTA DA neurons projecting to different target areas may account for the varying physiological or pathological characteristics. Mediation of depression by VTA → mPFC pathway and of nociception-related responses by VTA → NAc pathway in our study is also consistent with previous researches. For example, optogenetic inhibition of the VTA → mPFC pathway induced social avoidance behavior in C57/BL6 mice subjected to subthreshold social defeat. 12 Some studies have demonstrated that the NAc was required for mediating nociceptive modulation by VTA DA neurons 2, 67 and activation of the VTA to NAc dopamine signaling contributed to both pain-related positively and negatively reinforced behaviors. 43 Based on the previous studies, 7, 18, 39 we focused on BDNF in the VTA → mPFC and VTA → NAc pathways to explore the molecular mechanisms underlying the antidepressant-like and nociceptive effects by the activation of VTA DA neurons in CMS mice. We demonstrated that normalized BDNF functions of the VTA → mPFC pathway are essential to the hyperalgesia in CMS-BDNF(NAc shell) group relative to the CMS-Sal(NAc shell) group: ***P , 0.001, n 5 8 mice/group). relief of depressive-like behaviors. Conversely, sequestration of endogenous BDNF with TrkB-Fc in the mPFC could reverse the antidepressant-like effects by the activation of the VTA DA neurons in CMS mice. Previous studies have shown that repeated stress induces dendritic atrophy in the rat mPFC. 10 Significant downregulation of BDNF expression in the mPFC was confirmed by autopsy in suicide victims with depression. 18 In addition, antidepressants may exert their efficacy by upregulating BDNF expression in rodents and the observed normalized BDNF levels in humans. 18, 39 BDNF/TrkB and its downstream signaling molecules might account for the modulatory effects of BDNF in depressive phenotypes. For example, BDNF regulated GSK-3b through PI3K/AKT signaling. 33 Chronic stress decreased the p-Ser9-GSK-3b expression in mPFC, 66 which strengthened GSK3b functions and consequently declined gene expression and synaptic functions. Conversely, exogenous BDNF might rescue the stressinduced changes in the BDNF-GSK-3b pathway and facilitate synaptic functions. Also, the BDNF/TrkB -MAPK/ERK cascade has been explored to be involved in the modulation of neuroplasticity and stress responses. 28 Intra-mPFC injection of BDNF might activate this pathway and stimulate downstream mammalian target of rapamycin (mTOR) signaling, 17 which increased synaptic proteins expression and synaptic transmission. Collectively, CMS-induced depressive-like behavior is associated with the downregulation of BDNF in the mPFC, whereas the activation of VTA DA neurons might facilitate the release of BDNF 28, 62 to the mPFC so as to attenuate depression.
We also found that the activation of VTA DA neurons in CMS mice promoted the release of the BDNF protein in the NAc shell. This result was consistent with the enhancement of NAc BDNF expression induced by the optogenetic activation of VTA → NAc neurons in mice subjected to subthreshold social defeat stress. 62 In addition to this, infusion of exogenous BDNF into the NAc shell induced a significant thermal nociceptive response, and the blockage of BDNF signaling in the NAc shell antagonized the intra-VTA morphine-induced nociception, suggesting a vital role of BDNF in the VTA → NAc pathway in nociceptive modulation. The NAc regulates the perception of noxious information and descending pain modulatory circuits. 4, 6, 21 Imaginal studies revealed activated NAc in humans with chronic pain. 5, 6 Imaging studies also demonstrated activated NAc in rats with peripheral nerve injury. 24 NAc serves to predict the value of a noxious thermal stimulus at its onset and offset. 5 The stimulation of the NAC provided relief from central poststroke pain in humans. 36 Our recent research also found that chronic constriction injury (CCI) of the sciatic nerve upregulated the BDNF expression in the contralateral NAc. 67 Moreover, the inhibition of BDNF synthesis in the VTA or selective knockdown of BDNF in the VTA → NAc pathway induced antinociceptive effects in CCI mice. 67 Together with these findings, our study provides evidence that VTA → NAc pathway BDNF signaling is a critical modulator of nociception in CMS mice. Despite the reported mechanisms that BDNF within the VTA → NAc circuit might mediate depressive-like behaviors in social defeat mice, 7 it is still less clear about the functions of BDNF in CMS, especially at the neural circuit levels. Social defeat stress alters the motivation for social interaction in rodents, which induces depressive-like phenotypes 7, 12 and might also relate to pertinent aspects of anxiety disorders. 61 Given the differences of schema and intensity of stressors involved in the CMS model and social defeat paradigm, it is relatively difficult to compare the roles of BDNF in the 2 animal models.
To help us to draw the conclusion from the present data, 3 points should be further clarified. First, CMS did not affect nociceptive threshold. The results were consistent with recent reports that basal thermal and mechanical pain threshold were not changed in CMS mice. 8, 23 However, studies also showed increased thermal and mechanical nociceptive thresholds in rats that underwent chronic stress, 53 as well as reduced nociceptive responses in CMS rats. 46 In addition, CMS might induce thermal hyperalgesia and mechanical allodynia. 35 These observations indicate that the effects of stress on pain threshold might depend on the procedures for CMS, and further studies are needed to explore the underlying mechanisms.
Second, both in vivo VTA recording and ex vivo VTA → mPFC DA neurons recording showed decreased firing rates in CMS mice. In vivo recording data might be collected from mixed populations of VTA DA neurons projecting to multiple target regions (eg, the mPFC, the NAc, the hippocampus, and the amygdala). Although chronic stress did not change the activity of VTA → NAc DA neurons, CMS decreased the firing rates of VTA → mPFC DA neurons. Also, we cannot exclude the possibility that chronic stress might decrease the activity of the hippocampus-or the amygdala-projecting VTA DA neurons. Therefore, during in vivo recording, the comprehensive outcomes of CMS could decrease the firing rates of VTA DA neurons. This study is also comparable to our previous findings that social defeat significantly increased the firing rates of VTA → NAc DA neurons, yet dramatically decreased VTA → mPFC DA neurons in brain slices. 12 However, the overall in vivo VTA firing rates were notably increased in social defeat mice. 11 Together, CMS decreased the firing rates of VTA → mPFC DA neurons ex vivo and the activity of VTA DA neurons in vivo.
The third is the finding of intra-VTA delivery of morphineinduced hyperalgesia, rather than analgesia. Although there was evidence showing that intra-VTA injection of morphine (3.0 mg/ 0.5 mL/side) inhibited formalin pain scores in rats, 1 few studies explored the effect of intra-VTA morphine on the basal nociceptive threshold. Our results showed that intra-VTA morphine (25.5 ng/0.15 mL) did not change the basal thermal nociceptive threshold in the control mice, but induced a significant thermal nociceptive response in CMS mice. Three possible reasons might account for the discrepancy: (1) a much lower dose of morphine was used in this study. The previous finding has shown that low doses in comparison to usual doses of morphine may have different effects and mechanisms in modulating nociception. 27 (2) The dose of morphine used in this study increased the firing activity in only stressed VTA DA neurons, suggesting a context gating mechanism. (3) The difference in animal species and methods for assessment of nociceptive behaviors.
In conclusion, we report that the activation of VTA DA neurons in CMS state produced antidepressant-like effects by BDNF signaling in the VTA → mPFC pathway, accompanied by thermal nociceptive responses mediated by BDNF signaling in the VTA → NAc pathway (Fig. 6) . Our findings revealed a novel role for projection-specific regulation of depressive-like and nociceptive behaviors by BDNF signaling in the mesolimbic reward circuitry.
